Infants today lose maternal measles antibody sooner than in the past.
This is related to demographic changes in maternal immunization. Data
for rates of decay of maternal antibody and seroconversion after measl
es vaccination for infants born to naturally immune (Group 1) or vacci
nated (Group 2) mothers have been used to evaluate two vaccination sch
edules: Regime 1, measles-mumps-rubella (MMR) at 1 year of age and Reg
ime 2, monovalent measles at 6 months followed by MMR at 15 months of
age. Regime 2 costs less because MMR can be administered at 15 months
with the last pentavalent booster. Months of protection/1000 children
aged 0-15 months (child-months of protection) were estimated for infan
t populations ranging from 0 to 100% Group 1 for Regimes 1 and 2. Regi
me 1 provides more child-months of protection only for 100% Group 1 po
pulations. For the study population Regime 2 provided at least 17% mor
e child-months of protection than Regime 1. Regime 2 provides increase
d medical and financial benefits in proportion to the number of Group
2 infants in the population and thus is ever more advantageous for tod
ay's increasingly vaccinated populations. (C) 1998 Elsevier Science Lt
d. All rights reserved.